Chemotherapy in the treatment of thymic tumors

by Marcello Tiseo, Andrea Ardizzoni
Published 2011-12-01

Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review

by Marcello Tiseo, Andrea Ardizzoni
Published 2011-12-01

Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review

by Marcello Tiseo, Andrea Ardizzoni
Published 2011-12-01

Systemic adjuvant therapies in renal cell carcinoma

by Sebastiano Buti, Melissa Bersanelli, Maddalena Donini, Andrea Ardizzoni
Published 2012-10-01

It Takes Two to Tango: How a Dysregulation of the Innate Immunity, Coupled With Candida Virulence, Triggers VVC Onset

by Andrea Ardizzoni, Robert T. Wheeler, Robert T. Wheeler, Eva Pericolini, Eva Pericolini
Published 2021-06-01

Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System

by Emanuel Raschi, Michele Fusaroli, Andrea Ardizzoni, Elisabetta Poluzzi, Fabrizio De Ponti
Published 2021-04-01

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporti...

by Milo Gatti, Emanuel Raschi, Ugo Moretti, Andrea Ardizzoni, Elisabetta Poluzzi, Igor Diemberger
Published 2021-01-01

Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers

by Francesca Giunchi, Francesco Massari, Annalisa Altimari, Elisa Gruppioni, Elisabetta Nobili, Michelangelo Fiorentino, Andrea Ardizzoni
Published 2020-12-01

Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

by Karim Rihawi, Francesco Gelsomino, Francesca Sperandi, Barbara Melotti, Michelangelo Fiorentino, Laura Casolari, Andrea Ardizzoni
Published 2017-09-01

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

by Giuseppe Lamberti, Monia Sisi, Elisa Andrini, Arianna Palladini, Francesca Giunchi, Pier-Luigi Lollini, Andrea Ardizzoni, Francesco Gelsomino
Published 2020-10-01

In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity.

by Andrea Ardizzoni, Eva Pericolini, Simona Paulone, Carlotta Francesca Orsi, Anna Castagnoli, Ilaria Oliva, Elena Strozzi, Elisabetta Blasi
Published 2018-01-01

Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro

by Eva Pericolini, Bruna Colombari, Gianmarco Ferretti, Ramona Iseppi, Andrea Ardizzoni, Massimo Girardis, Arianna Sala, Samuele Peppoloni, Elisabetta Blasi
Published 2018-08-01

Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling

by Maria A. Pantaleo, Maria A. Pantaleo, Marcella Mandruzzato, Valentina Indio, Milena Urbini, Margherita Nannini, Lidia Gatto, Angela Schipani, Michelangelo Fiorentino, Tania Franceschini, Valentina Ambrosini, Valerio Di Scioscio, Maristella Saponara, Manuela Ianni, Sergio Concetti, Annalisa Altimari, Andrea Ardizzoni, Andrea Ardizzoni, Annalisa Astolfi
Published 2021-03-01

IFN-γ and CD38 in Hyperprogressive Cancer Development

by Stefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, Laura Scalambra, Francesco Gelsomino, Andrea Ardizzoni, Patrizia Nanni, Pier-Luigi Lollini, Arianna Palladini
Published 2021-01-01

Circulating tumor cells in genitourinary tumors

by Francesco Massari, Vincenzo Di Nunno, Francesca Comito, Marta Cubelli, Chiara Ciccarese, Roberto Iacovelli, Michelangelo Fiorentino, Rodolfo Montironi, Andrea Ardizzoni
Published 2018-02-01

New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event

by Giuseppe Lamberti, Francesco Gelsomino, Stefano Brocchi, Antonio Poerio, Barbara Melotti, Francesca Sperandi, Mauro Gargiulo, Claudio Borghi, Michelangelo Fiorentino, Andrea Ardizzoni
Published 2020-07-01

Programmed Cell Death Protein-1 Inhibitors Versus Programmed Death-Ligand 1 Inhibitors in Addition to Chemotherapy for the First-Line Treatment of Advanced NSCLC: A Systematic Revi...

by Alessandro Di Federico, MD, Andrea De Giglio, MD, Claudia Parisi, MD, Francesco Gelsomino, MD, Luca Boni, MD, Andrea Ardizzoni, Prof
Published 2021-09-01

A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy

by Valerio Gelfo, Martina Mazzeschi, Giada Grilli, Moshit Lindzen, Spartaco Santi, Gabriele D’Uva, Balázs Győrffy, Andrea Ardizzoni, Yosef Yarden, Mattia Lauriola
Published 2018-09-01

CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors

by Filippo G. Dall’Olio, Francesca Abbati, Francesco Facchinetti, Maria Massucci, Barbara Melotti, Anna Squadrilli, Sebastiano Buti, Francesca Formica, Marcello Tiseo, Andrea Ardizzoni
Published 2020-10-01

Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study

by Costantino Ricci, Elisa Capizzi, Francesca Giunchi, Laura Casolari, Francesco Gelsomino, Karim Rihawi, Filippo Natali, Vanina Livi, Rocco Trisolini, Michelangelo Fiorentino, Andrea Ardizzoni
Published 2020-11-01